EKF Diagnostics Holdings Plc is a vitro diagnostics company, which engages in the designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan and currently employs 297 full-time employees. The company went IPO on 2002-06-05. The firm develops and produces in-vitro diagnostic (IVD) devices and tests designed for use at or near the patient’s location. The company provides a suite of products for diabetes management, including glucose monitoring systems and associated consumables. The company offers devices, supplies, and consumables for measuring hemoglobin levels, including tools for detecting hemoglobin variants. The company also develops and supplies diagnostic and therapeutic enzymes, proteins, reagents, and biomaterials. The company provides precision fermentation, custom bioprocessing, and contract manufacturing services for pharmaceuticals and other biological products. The company supplies beta-hydroxybutyrate (HB) products used in ketone detection to support the diagnosis of diabetic ketoacidosis and other clinical conditions.
Mr. Gavin Jones es el Chief Executive Officer de EKF Diagnostics Holdings plc, se unió a la empresa desde 2025.
¿Qué tal es el rendimiento del precio de la acción EKF DIAGNOSTICS HOLDINGS PLC?
El precio actual de EKF DIAGNOSTICS HOLDINGS PLC es de $0.3398, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de EKF Diagnostics Holdings plc?
EKF Diagnostics Holdings plc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de EKF Diagnostics Holdings plc?
La capitalización bursátil actual de EKF Diagnostics Holdings plc es $146.6M
¿Es EKF Diagnostics Holdings plc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 6 analistas han realizado calificaciones de análisis para EKF Diagnostics Holdings plc, incluyendo 4 fuerte compra, 6 compra, 1 mantener, 0 venta, y 4 fuerte venta